Metlife (MET) Stock Forecast & Price Target

Compare

2,941 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MET Analyst Ratings

Strong Buy

10 Buy

2 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Metlife

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MET Stock 12 Month Forecast

Average Price Target

$93.83

▲(22.22% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Metlife in the last 3 months. The average price target is $93.83 with a high forecast of $102.00 and a low forecast of $84.00. The average price target represents a 22.22% change from the last price of $76.77.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"71":"$71","79":"$79","87":"$87","95":"$95","103":"$103"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":102,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$102.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":93.83,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$93.83</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":84,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$84.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[71,79,87,95,103],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,78.94,80.71384615384615,82.4876923076923,84.26153846153846,86.03538461538461,87.80923076923077,89.58307692307692,91.35692307692308,93.13076923076923,94.90461538461538,96.67846153846153,98.4523076923077,100.22615384615385,{"y":102,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,78.94,80.08538461538461,81.23076923076923,82.37615384615384,83.52153846153846,84.66692307692307,85.81230769230768,86.9576923076923,88.10307692307693,89.24846153846154,90.39384615384616,91.53923076923077,92.68461538461538,{"y":93.83,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,78.94,79.32923076923076,79.71846153846154,80.1076923076923,80.49692307692308,80.88615384615385,81.27538461538461,81.66461538461539,82.05384615384615,82.44307692307692,82.8323076923077,83.22153846153846,83.61076923076924,{"y":84,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":79.574,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.074,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.291,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.381,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.109,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.523,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.898,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.922,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.777,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.343,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.248,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.31,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.94,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$102.00

Average Price Target$93.83

Lowest Price Target$84.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Joshua Shanker

Bank of America Securities

$98→$97

Buy

26.35%

Upside

Reiterated

01/16/26

Metlife (MET) Gets a Buy from Bank of America Securities

Yaron Kinar

Mizuho Securities

$101→$102

Buy

32.86%

Upside

Reiterated

01/14/26

MetLife price target raised to $102 from $101 at MizuhoMetLife price target raised to $102 from $101 at Mizuho

Elyse Greenspan

Wells Fargo

$94→$97

Buy

26.35%

Upside

Reiterated

01/13/26

MetLife price target raised to $97 from $94 at Wells FargoMetLife price target raised to $97 from $94 at Wells Fargo

Michael Ward CFA

UBS

$95→$94

Buy

22.44%

Upside

Reiterated

01/08/26

Analysts Have Conflicting Sentiments on These Financial Companies: Morgan Stanley (NYSE: MS) and Metlife (NYSE: MET)

Alex Scott

Barclays

$98→$90

Buy

17.23%

Upside

Reiterated

01/08/26

MetLife price target lowered to $90 from $98 at BarclaysMetLife price target lowered to $90 from $98 at Barclays

Thomas Gallagher

Evercore ISI

$108→$97

Hold

26.35%

Upside

Downgraded

01/06/26

Metlife (MET) was downgraded to a Hold Rating at Evercore ISI

Jimmy Bhullar

J.P. Morgan

$93

Buy

21.14%

Upside

Reiterated

01/05/26

J.P. Morgan Reaffirms Their Buy Rating on Metlife (MET)

John Barnidge

Piper Sandler

$84

Hold

9.42%

Upside

Reiterated

12/23/25

Piper Sandler Reaffirms Their Hold Rating on Metlife (MET)

Bob Huang

Morgan Stanley

$97→$101

Buy

31.56%

Upside

Reiterated

12/15/25

MetLife price target raised to $101 from $97 at Morgan StanleyMetLife price target raised to $101 from $97 at Morgan Stanley

Andrew Kligerman

TD Cowen

$91

Buy

18.54%

Upside

Reiterated

12/12/25

TD Cowen Sticks to Its Buy Rating for Metlife (MET)

Kevin Heal

Argus Research

$90

Buy

17.23%

Upside

Reiterated

12/08/25

MetLife's higher investment income supporting results, says ArgusMetLife's higher investment income supporting results, says Argus

Ryan Krueger

KBW

$92→$90

Buy

17.23%

Upside

Reiterated

11/11/25

MetLife price target lowered to $90 from $92 at Keefe BruyetteMetLife price target lowered to $90 from $92 at Keefe Bruyette

Jack Matten

BMO Capital

$82→$84

Hold

9.42%

Upside

Reiterated

09/30/25

BMO Capital Keeps Their Hold Rating on Metlife (MET)

Tracy Benguigui

Wolfe Research

$95

Buy

23.75%

Upside

Initiated

09/15/25

MetLife initiated with an Outperform at Wolfe ResearchMetLife initiated with an Outperform at Wolfe Research

Suneet Kamath

Jefferies

$100→$103

Buy

34.17%

Upside

Reiterated

08/11/25

Jefferies Reaffirms Their Buy Rating on Metlife (MET)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Joshua Shanker

Bank of America Securities

$98→$97

Buy

26.35%

Upside

Reiterated

01/16/26

Metlife (MET) Gets a Buy from Bank of America Securities

Yaron Kinar

Mizuho Securities

$101→$102

Buy

32.86%

Upside

Reiterated

01/14/26

MetLife price target raised to $102 from $101 at MizuhoMetLife price target raised to $102 from $101 at Mizuho

Elyse Greenspan

Wells Fargo

$94→$97

Buy

26.35%

Upside

Reiterated

01/13/26

MetLife price target raised to $97 from $94 at Wells FargoMetLife price target raised to $97 from $94 at Wells Fargo

Michael Ward CFA

UBS

$95→$94

Buy

22.44%

Upside

Reiterated

01/08/26

Analysts Have Conflicting Sentiments on These Financial Companies: Morgan Stanley (NYSE: MS) and Metlife (NYSE: MET)

Alex Scott

Barclays

$98→$90

Buy

17.23%

Upside

Reiterated

01/08/26

MetLife price target lowered to $90 from $98 at BarclaysMetLife price target lowered to $90 from $98 at Barclays

Thomas Gallagher

Evercore ISI

$108→$97

Hold

26.35%

Upside

Downgraded

01/06/26

Metlife (MET) was downgraded to a Hold Rating at Evercore ISI

Jimmy Bhullar

J.P. Morgan

$93

Buy

21.14%

Upside

Reiterated

01/05/26

J.P. Morgan Reaffirms Their Buy Rating on Metlife (MET)

John Barnidge

Piper Sandler

$84

Hold

9.42%

Upside

Reiterated

12/23/25

Piper Sandler Reaffirms Their Hold Rating on Metlife (MET)

Bob Huang

Morgan Stanley

$97→$101

Buy

31.56%

Upside

Reiterated

12/15/25

MetLife price target raised to $101 from $97 at Morgan StanleyMetLife price target raised to $101 from $97 at Morgan Stanley

Andrew Kligerman

TD Cowen

$91

Buy

18.54%

Upside

Reiterated

12/12/25

TD Cowen Sticks to Its Buy Rating for Metlife (MET)

Kevin Heal

Argus Research

$90

Buy

17.23%

Upside

Reiterated

12/08/25

MetLife's higher investment income supporting results, says ArgusMetLife's higher investment income supporting results, says Argus

Ryan Krueger

KBW

$92→$90

Buy

17.23%

Upside

Reiterated

11/11/25

MetLife price target lowered to $90 from $92 at Keefe BruyetteMetLife price target lowered to $90 from $92 at Keefe Bruyette

Jack Matten

BMO Capital

$82→$84

Hold

9.42%

Upside

Reiterated

09/30/25

BMO Capital Keeps Their Hold Rating on Metlife (MET)

Tracy Benguigui

Wolfe Research

$95

Buy

23.75%

Upside

Initiated

09/15/25

MetLife initiated with an Outperform at Wolfe ResearchMetLife initiated with an Outperform at Wolfe Research

Suneet Kamath

Jefferies

$100→$103

Buy

34.17%

Upside

Reiterated

08/11/25

Jefferies Reaffirms Their Buy Rating on Metlife (MET)

Stocks with the Highest Top Analyst Consensus in the Financial Sector

xxx

Find stocks in the Financial sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Metlife

3 Months

xxx

Success Rate

23/35 ratings generated profit

Average Return

+4.16%

reiterated a xxx

rating 5 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 65.71% of your transactions generating a profit, with an average return of +4.16% per trade.

1 Year

Ryan KruegerKBW

Success Rate

28/32 ratings generated profit

Average Return

+15.93%

reiterated a buy rating 2 months ago

Copying Ryan Krueger's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +15.93% per trade.

2 Years

xxx

Success Rate

27/32 ratings generated profit

Average Return

+16.65%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 84.38% of your transactions generating a profit, with an average return of +16.65% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MET Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MET has received 36 Buy Ratings, 16 Hold Ratings, and 0 Sell Ratings. MET average Analyst price target in the past 3 months is 93.83.

Each month's total comprises the sum of three months' worth of ratings.

MET Financial Forecast

MET Earnings Forecast

Next quarter’s earnings estimate for MET is $2.34 with a range of $2.25 to $2.46. The previous quarter’s EPS was $2.34. MET beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 65.60% of the time in the same period. In the last calendar year MET has Performed in-line its overall industry.

MET Sales Forecast

Next quarter’s sales forecast for MET is $27.22B with a range of $18.33B to $31.26B. The previous quarter’s sales results were $17.36B. MET beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 79.60% of the time in the same period. In the last calendar year MET has Performed in-line its overall industry.

MET Stock Forecast FAQ

What is MET’s average 12-month price target, according to analysts?

Based on analyst ratings, Metlife’s 12-month average price target is 93.83.

What is MET’s upside potential, based on the analysts’ average price target?

Metlife has 22.22% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MET a Buy, Sell or Hold?

Metlife has a consensus rating of Strong Buy which is based on 10 buy ratings, 2 hold ratings and 0 sell ratings.

What is Metlife’s price target?

The average price target for Metlife is 93.83. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $102.00 ,the lowest forecast is $84.00. The average price target represents 22.22% Increase from the current price of $76.77.

What do analysts say about Metlife?

Metlife’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of MET?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Metlife (MET) Stock Forecast & Price Target

MET Analyst Ratings

MET Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Metlife

MET Analyst Recommendation Trends

MET Financial Forecast

MET Earnings Forecast

MET Sales Forecast

MET Stock Forecast FAQ

Detailed List of Analyst Forecasts